U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
8493184931A Trial Comparing Breakfast Versus no Breakfast Prior to ColonoscopyCompletedNo Results AvailableClinically Indicated ColonoscopyOther: breakfasthttps://ClinicalTrials.gov/show/NCT01454388
8493284932Emergency Department Smoking Cessation StudyCompletedNo Results AvailableTobacco Use CessationBehavioral: Referral to QuitNow Serviceshttps://ClinicalTrials.gov/show/NCT01454375
8493384933Effect of the Electronic Cigarette on Withdrawal SymptomsCompletedNo Results AvailableMental and Behavioral Disorders|Withdrawal StateDrug: Nicotinehttps://ClinicalTrials.gov/show/NCT01454362
8493484934Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH)CompletedNo Results AvailableBenign Prostatic HyperplasiaDrug: PRX302|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01454349
8493584935Transplantation of Autologous Mesenchymal Stem Cell in Decompensate Cirrhotic Patients With PioglitazoneCompletedNo Results AvailableLiver FibrosisBiological: Cell injectionhttps://ClinicalTrials.gov/show/NCT01454336
8493684936Intracoronary Infusion of Bone Marrow Mononuclear Cells in Patients With Previous Myocardial Infarction.CompletedNo Results AvailableChronic Myocardial IschemiaOther: Bone marrow mononuclear cellshttps://ClinicalTrials.gov/show/NCT01454323
8493784937An Acellular Epithelial Skin Substitute in Deep Partial-thickness BurnsCompletedNo Results AvailableWound Healing|Scar FormationDevice: Wound coverage by acellular skin substitute|Device: Autologous skinhttps://ClinicalTrials.gov/show/NCT01454310
8493884938Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic ProfileActive, not recruitingNo Results AvailableMultiple Myelomahttps://ClinicalTrials.gov/show/NCT01454297
8493984939A Study in Patients With Type I Diabetes MellitusCompletedNo Results AvailableDiabetes Mellitus, Type 1Drug: Glargine|Drug: LY2605541|Drug: Insulin Lisprohttps://ClinicalTrials.gov/show/NCT01454284
8494084940Follow up Study of Patients Undergoing Total Hip Arthroplasty CERAFIT® Grafted With Poly Sodium Styrene SulfonateNot yet recruitingNo Results AvailableHip Arthroplasty ReplacementProcedure: Total Hip Arthroplasty Replacementhttps://ClinicalTrials.gov/show/NCT01454271
8494184941Indication for Intraoperative Volume TherapyCompletedNo Results AvailablePatients Undergoing Any Kind of Surgeryhttps://ClinicalTrials.gov/show/NCT01454258
8494284942A Study to Evaluate the Bioavailability and Food Effect of JNJ-39439335 in Healthy Adult Male VolunteersCompletedNo Results AvailableHealthyDrug: JNJ-39439335|Drug: JNJ-39439335https://ClinicalTrials.gov/show/NCT01454245
8494384943Adaptation of Human Gut Microbiota to Energetic RestrictionRecruitingNo Results AvailableObesity|Metabolic Diseases|Nutrition Disorders|Body WeightOther: stools sampling|Other: adipose tissue biopsyhttps://ClinicalTrials.gov/show/NCT01454232
8494484944Measurement of Glycaemic Responses of Bakery and Confectionery ProductsCompletedNo Results AvailableHealthyOther: Bakery and confectionary productshttps://ClinicalTrials.gov/show/NCT01454219
8494584945Integration of (iSBIRT) for Teen Drug Use Into a Pediatric NetworkWithdrawnNo Results AvailableSubstance UseBehavioral: iSBIRThttps://ClinicalTrials.gov/show/NCT01454206
8494684946Are we Loading Our Patients With Sodium During Hemodialysis Treatments?CompletedNo Results AvailableRenal Failurehttps://ClinicalTrials.gov/show/NCT01454193
8494784947Study of Individualized Selection of Chemotherapy in Patients With Advanced Pancreatic Carcinoma According to Therapeutic TargetsRecruitingNo Results AvailableAdvanced Pancreatic CarcinomaDrug: gemcitabine, or gemcitabine and capecitabine, or gemcitabine and erlotinib, or FOLFIRINOX, or FOLFOX, or FOLFIRI.|Drug: Gemcitabine, Gemcitabine-Capecitabine, Gemcitabine-Erlotinib, FOLFOXIRI, FOLFOX, FOLFIRIhttps://ClinicalTrials.gov/show/NCT01454180
8494884948Acid Base and Electrolytes Patterns in Drains Operational Wounds and Its Relation to ComplicationsRecruitingNo Results AvailableWounds|Infections|Seromahttps://ClinicalTrials.gov/show/NCT01454167
8494984949Glyburide (RP-1127) for Traumatic Brain Injury (TBI)Active, not recruitingNo Results AvailableTraumatic Brain InjuryDrug: Glyburide|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01454154
8495084950Cognitive Control Training for DepressionCompletedNo Results AvailableDepressionOther: Cognitive Control Training|Other: Peripheral Vision Taskhttps://ClinicalTrials.gov/show/NCT01454141
8495184951The Role of Exercise-Periodic-Breathing (EPB) in Impaired Ventilation Regulation Dysfunction in Heart Failure PatientsRecruitingNo Results AvailableImpaired Oxygen Delivery|Ischemic Reperfusion InjuryBehavioral: exercisehttps://ClinicalTrials.gov/show/NCT01454128
8495284952Study to Evaluate the Safety, Pharmacokinetics and Tolerability of BMS-708163CompletedNo Results AvailableAlzheimer's DiseaseDrug: BMS-708163 (Gamma-Secretase Inhibitor)|Drug: BMS-708163 (Gamma-Secretase Inhibitor)|Drug: BMS-708163 (Gamma-Secretase Inhibitor)|Drug: BMS-708163 (Gamma-Secretase Inhibitor)|Drug: BMS-708163 (Gamma-Secretase Inhibitor)|Drug: BMS-708163 (Gamma-Secretase Inhibitor)|Drug: BMS-708163 (Gamma-Secretase Inhibitor)|Drug: BMS-708163 (Gamma-Secretase Inhibitor)|Drug: BMS-708163 (Gamma-Secretase Inhibitor)|Drug: BMS-708163 (Gamma-Secretase Inhibitor)|Drug: Placebo matching BMS-708163|Drug: Placebo matching BMS-708163https://ClinicalTrials.gov/show/NCT01454115
8495384953Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (ChActive, not recruitingNo Results AvailableNon-small Cell Lung CancerBiological: Nivolumab|Drug: Gemcitabine|Drug: Cisplatin|Drug: Pemetrexed|Drug: Paclitaxel|Drug: Carboplatin|Drug: Bevacizumab|Drug: Erlotinib|Biological: Ipilimumabhttps://ClinicalTrials.gov/show/NCT01454102
8495484954A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder CancerCompletedNo Results AvailableUrologic Neoplasms|Metastatic Bladder Cancer|Urinary Tract NeoplasmsDrug: OGX-427 600 mg|Drug: OGX-427 1000 mg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01454089
8495584955Phase 1 Pharmacokinetics Study of Oral IXAZOMIB in Patients With Advanced Nonhematologic Malignancies or LymphomaActive, not recruitingNo Results AvailableNonhematologic Malignancies|LymphomaDrug: IXAZOMIB Capsule B formulation|Drug: IXAZOMIB Capsule A formulation|Drug: ketoconazole|Drug: rifampin|Drug: Drug: clarithromycinhttps://ClinicalTrials.gov/show/NCT01454076
8495684956Safety and Efficacy of OMS302 in Subjects Undergoing Intraocular Lens Replacement With PhacoemulsificationCompletedHas ResultsIntraocular Lens ReplacementDrug: OMS302|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01454063
8495784957Lumax 740 Master StudyCompletedNo Results AvailableSafety and Efficacy of the Lumax 740 ICD Familyhttps://ClinicalTrials.gov/show/NCT01454050
8495884958Immune Profiles and Circulating Tumor Cell Status Following Prostate CryotherapyRecruitingNo Results AvailableProstate Cancer|Immune Profile|Circulating Cancer Cells|Clinical CorelationProcedure: Prostate cryotherapy|Procedure: Radical prostatectomy|Procedure: Radiationhttps://ClinicalTrials.gov/show/NCT01454037
8495984959Evaluating Safety of NovoPen® 3 and/or FlexPen® Devices in Routine Clinical PracticeCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2|Delivery SystemsDevice: FlexPen®|Device: NovoPen® 3https://ClinicalTrials.gov/show/NCT01454024
8496084960The Effect of Testosterone Replacement on the High Density Lipoprotein Cholesterol SubgroupsCompletedNo Results AvailableSecondary HypogonadismDrug: Testosteron 250mg injection|Drug: Testosterone 50mg transdermal applicationhttps://ClinicalTrials.gov/show/NCT01454011

* Görseller ve İçerik tekif hakkına sahip olabilir